» Authors » Eino Solje

Eino Solje

Explore the profile of Eino Solje including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 390
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Berg A, Issakainen M, Ervasti K, Montonen T, Solje E, Maki-Petaja-Leinonen A
J Cross Cult Gerontol . 2025 Mar; PMID: 40053298
Older people's immigration to a different country can place them in a vulnerable situation. Research on the legal rights and access to justice for older immigrants and immigrants with dementia...
2.
Heikkinen S, Katisko K, Haapasalo A, Portaankorva A, Hartikainen P, Solje E
J Alzheimers Dis . 2025 Feb; :13872877251316804. PMID: 39956963
Background: Differentiating neurodegenerative diseases can be difficult in the clinical setting. This study examines the overlap of diagnostic criteria between frontotemporal dementia (FTD) syndromes with parkinsonism [e.g., corticobasal syndrome (CBS),...
3.
4.
Soiniemi L, Solje E, Suominen A, Kanninen K, Kullaa A
J Alzheimers Dis . 2024 Nov; 102(3):577-586. PMID: 39529279
Background: The association between cognitive neurodegenerative disease and oral diseases has been under great interest recently. Several studies have suggested a connection between periodontitis and Alzheimer's disease (AD) or other...
5.
Jy Kang M, Grewal J, Eratne D, Malpas C, Chiu W, Katisko K, et al.
Brain Behav Immun . 2024 Nov; 123():1091-1102. PMID: 39510417
Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) are biomarkers of neuronal injury measurable in cerebrospinal fluid (CSF) and blood. Despite their potential as diagnostic tests for neurodegenerative...
6.
Borroni B, Tarantino B, Graff C, Kruger J, Ludolph A, Moreno F, et al.
Neurology . 2024 Sep; 103(7):e209793. PMID: 39226519
Background And Objectives: Data on care home admission and survival rates of patients with syndromes associated with frontotemporal lobar degeneration (FTLD) are limited. However, their estimation is essential to plan...
7.
Kolasa M, Arponen O, Kaartinen I, Saarinen E, Solje E, Hirvonen J, et al.
J Diabetes Complications . 2024 Jul; 38(9):108829. PMID: 39059188
Aims: This study assessed whether changes associated with cerebral small vessel disease (CSVD) evaluated from head computed tomography (CT) images captured for non-related clinical purposes predict overall survival (OS), leg...
8.
Kruger J, Aaltonen M, Aho K, Heikkinen S, Kivisild A, Lehtonen A, et al.
Neurology . 2024 Jul; 103(4):e209654. PMID: 39047214
Objectives: Current epidemiologic data of early-onset dementia (EOD), characterized by the onset of the disease before the age of 65, are notably scarce. Methods: We evaluated the incidence (from January...
9.
Nakki K, Maki-Petaja-Leinonen A, Ervasti K, Halkoaho A, Nurmi S, Solomon A, et al.
Eur J Neurol . 2024 May; 31(8):e16334. PMID: 38733099
Background: Dementia is assumed to alter mental capacity, which may necessitate legal guardianship. However, only limited research exists on how dementia affects mental capacity, and most studies have focused solely...
10.
Italia M, Salvade M, La Greca F, Zianni E, Pelucchi S, Spinola A, et al.
Brain Behav Immun . 2024 Mar; 118:380-397. PMID: 38485064
Autoantibodies directed against the GluA3 subunit (anti-GluA3 hIgGs) of AMPA receptors have been identified in 20%-25% of patients with frontotemporal lobar degeneration (FTLD). Data from patients and in vitro/ex vivo...